New scan could spot childhood cancer more clearly
NCT ID NCT06858501
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This study tests whether a new type of PET scan (18F-MFBG) can detect neuroblastoma tumors as accurately as the current standard scan (123I-MIBG). About 84 children and adults with newly diagnosed, high-risk neuroblastoma will receive both scans to compare results. If the new scan works as well or better, it could become a new tool for diagnosing and monitoring this cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GANGLIONEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immunotherapy boosts chemo against tough childhood cancer
- New antibody combo shows promise in tough childhood cancer
- Experimental cancer therapy targets tough tumors with radioactive precision
- New vaccine aims to train immune system to attack childhood cancer
- Engineered immune cells take aim at childhood cancer
- New drug combo shows promise against childhood cancer